의료진 소개
노우철
유방암센터장
[
외과,
유방암센터,
갑상선암센터
]
유방암
외래진료 외래진료
특수클리닉 특수클리닉
진료일정
04
| 날짜 |
|---|
| 오전 |
| 오후 |
논문
논문
- Chung HW, So Y, Noh WC, Yoo YB, Nam SE, Park KS. PET/MRI and Novel Targets for Breast Cancer. Biomedicines. 2024 Jan;12(1):172.
- Noh WC. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial. Journal of Clinical Oncology. 2023 Nov;41(31):4864-71.
- Noh WC. Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?. Annals of Surgical Treatment and Research. 2023 Jul;105(1):31-6.
- Noh WC. Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy. Annals of Surgical Treatment and Research. 2023 Jul;105(1):1-9.
- Nam SE, Noh WC, Yoo YB, Yoon IJ, Park KS. Vitamin D receptor (VDR) mRNA overexpression is associated with poor prognosis in breast carcinoma. Annals of Surgical Treatment and Research. 2022 Oct;103(4):183-94.
- Cho JH, So Y, Yoo YB, Park KS, Nam SE, Noh WC, Chung HW. FDG PET/CT to Predict Recurrence of Early Breast Invasive Ductal Carcinoma. Diagnostics. 2022 Mar;12(3):694.
- Noh WC. The Prediction of HER2-Targeted Treatment Response Using 64Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report. Journal of Breast Cancer. 2022 Feb;25(1):69-73.
- Noh WC. miR-3188 Enhances Sensitivity of Breast Cancer Cells to Ionizing Radiation by Down-regulating Rictor. Anticancer Research. 2021 Dec;41(12):6169-76.
- Kim JH, Park S, Park HS, Park JS, Lee ST, Kim SW, Lee JW, Lee MH, Park SK, Noh WC, Choi DH, Han W, Jung SH. Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer Study. Sci Rep. 2021/11/1/8485.
- Lee I, Lim I, Byun BH, Kim BI, Choi CW, Woo SK, Kim KI, Lee KC, Kang JH, Seong MK, Kim HA, Noh WC, Lim SM. A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer. EJNMMI Res. 2021/11/1/8.
- Kim HJ, Noh WC, Nam SJ, Park BW, Lee ES, Im SA, Jung YS, Yoon JH, Kang SS, Park KH, Lee SJ, Jeong J, Lee MH, Cho SH, Kim SY, Kim HA, Han SH, Han W, Hu MH, Kim S, Ahn SH. Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report. Eur J Cancer . 2021/151/190-200.
- Jang YJ, Oh SJ, Choi H, Cho S, Shin CH, Kim C, Woo J, Lee J, Park HK, Lee HB, Noh WC, Kim YS. Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean Breast Cancer Society. Breast Cancer Res Treat. 2021/186/1/125-134.